Mice homozygous for this Gsk3b conditional mutation express greatly reduced levels of a destabilized protein. When treated with rapamycin, functional protein expression is restored. This strain may be useful in studies of diabetes, inflammation, cardiovascular disease, cancer, neurodegenerative disease, and bipolar disorder.
Gerald R Crabtree, Stanford University Medical Center
In this Gsk3b (glycogen synthase kinase 3 beta) conditional mutant, a modified rapamycin-binding domain derived from the mouse Mtor gene, flagged with a hemagglutinin tag (FRB*HA), takes the place of the endogenous stop codon, destabilizing the protein product. Homozygous mice die shortly after birth. The cause of death is not formally known, but mice are born with a cleft palate, sternal fusion defects, and they fail to nurse. Transcript levels and expression patterns reflect those of wildtype mice, but protein levels are are greatly reduced. Heterozygous mice are viable and appear normal.
Administration of rapamycin or a nontoxic, non-teratogenic, membrane-permeable rapamycin derivative (C20-methallylrapamycin; C20-MaRap), can re-establish stability and functional kinase activity of the protein as it binds to the ubiquitously expressed FKBP12 protein. C20-MaRap-mediated stabilization can be rapidly reversed by the addition of an FKBP12 binding competitor.
Gsk3b is a serine-threonine kinase involved in a range of biological processes including neurodevelopment, insulin-dependent glycogen synthesis, cellular proliferation and differentiation.
This strain may be useful in studies of diabetes, inflammation, cardiovascular disease, cancer, neurodegenerative disease, and bipolar disorder.
A loxP-flanked neomycin resistance cassette was cloned into the last intron of the targeted gene, and an FRB*HA sequence was inserted in place of the normal stop codon. FRB*HA encodes a K2095P, T2098L, W2101F mutant form of the FKBP-rapamycin binding (Frb) domain of Mtor (mechanistic target of rapamycin (serine/threonine kinase); FRAP) fused to hemagglutinin. The targeting vector was electroporated into TC1 129S6/SvEvTac-derived embryonic stem (ES) cells. The neomycin cassette was deleted by crossing resultant animals with mice expressing Cre recombinase from the β actin promoter (genetic background unknown). This strain was maintained on a mixed background incorporating 129S1/SvImJ and C57BL/6 by the donating laboratory. CD1 crosses are also mentioned in the primary reference.
|Allele Name||targeted mutation 1, Gerald R Crabtree|
|Allele Type||Targeted (Null/Knockout)|
|Gene Symbol and Name||Gsk3b, glycogen synthase kinase 3 beta|
|Strain of Origin||129S6/SvEvTac|
|Molecular Note||A mutant FRB tag, composed of an 89 amino acids with three point mutations (K2095P, T2098L, and W2101F), was targeted into the C terminus of the locus. A floxed neo cassette was inserted into the last intron and an FRB*HA sequence placed immediately before the stop codon. The neo was subsequently removed via crossing with mice expressing cre recombinase in the germline. Presence of this mutant FRB tag destabilizes the protein resulting in decrease or loss of expression. Addition of rapamycin or a rapamycin analogue stabilizes the protein and restores expression.|
|Mutations Made By|| |
Gerald Crabtree, Stanford University Medical Center
Heterozygotes are viable and fertile, but homozygotes die shortly after birth.
When using the STOCK Gsk3btm1Grc/J mouse strain in a publication, please cite the originating article(s) and include JAX stock #017693 in your Materials and Methods section.
"MICE" means mouse strains, their progeny derived by inbreeding or crossbreeding, unmodified derivatives from mouse strains or their progeny supplied by The Jackson Laboratory ("JACKSON"). "PRODUCT(S)" means biological materials supplied by JACKSON, and their derivatives. "SERVICES" means projects conducted by JACKSON for other parties that may include but are not limited to the use of MICE or PRODUCTS. "RECIPIENT" means each recipient of MICE, PRODUCTS, or SERVICES provided by JACKSON including each institution, its employees and other researchers under its control. MICE or PRODUCTS shall not be: (i) used for any purpose other than internal research, (ii) sold or otherwise provided to any third party for any use, or (iii) provided to any agent or other third party to provide breeding or other services. Acceptance of MICE, PRODUCTS or SERVICES from JACKSON shall be deemed as agreement by RECIPIENT to these conditions, and departure from these conditions requires JACKSON’s prior written authorization.
MICE, PRODUCTS AND SERVICES ARE PROVIDED "AS IS". JACKSON EXTENDS NO WARRANTIES OF ANY KIND, EITHER EXPRESS, IMPLIED, OR STATUTORY, WITH RESPECT TO MICE, PRODUCTS OR SERVICES, INCLUDING ANY IMPLIED WARRANTY OF MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE, OR ANY WARRANTY OF NON-INFRINGEMENT OF ANY PATENT, TRADEMARK, OR OTHER INTELLECTUAL PROPERTY RIGHTS.
In case of dissatisfaction for a valid reason and claimed in writing by a purchaser within ninety (90) days of receipt of, PRODUCTS or SERVICES, JACKSON will, at its option, provide credit or replacement for the PRODUCT received or the SERVICES provided; JACKSON makes no other representations and this shall be the exclusive remedy of the purchaser. Please note specific policy for live mice.
Consistent with the requirement for a written understanding regarding animal care and use, the JACKSON Animal Care and Use Committee will review the animal care and use protocol(s) associated with any SERVICES to be performed at JACKSON, and JACKSON shall have ultimate responsibility and authority for the care of animals while on site or in JACKSON custody.
In no event shall JACKSON, its trustees, directors, officers, employees, and affiliates be liable for any causes of action or damages, including any direct, indirect, special, or consequential damages, arising out of the provision of MICE, PRODUCTS, or SERVICES, including economic damage or injury to property and lost profits, and including any damage arising from acts or negligence on the part of JACKSON, its agents or employees. Unless prohibited by law, in purchasing or receiving MICE, PRODUCTS, or SERVICES from JACKSON, purchaser or recipient, or any party claiming by or through them, expressly releases and discharges JACKSON from all such causes of action or damages, and further agrees to defend and indemnify JACKSON from any costs or damages arising out of any third party claims.
MICE, PRODUCTS or SERVICES are to be used in a safe manner and in accordance with all applicable governmental rules and regulations.
The foregoing represents the General Terms and Conditions applicable to JACKSON’s MICE, PRODUCTS or SERVICES. In addition, special terms and conditions of sale of certain MICE, PRODUCTS, or SERVICES may be set forth separately in JACKSON web pages, catalogs, price lists, contracts, and/or other documents, and these special terms and conditions shall also govern the sale of these MICE, PRODUCTS and SERVICES by JACKSON, and by its licensees and distributors.
Acceptance of delivery of MICE, PRODUCTS or SERVICES shall be deemed agreement to these terms and conditions. No purchase order or other document transmitted by purchaser or recipient that may modify the terms and conditions hereof, shall be in any way binding on JACKSON, and instead the terms and conditions set forth herein, including any special terms and conditions set forth separately, shall govern the sale of MICE, PRODUCTS or SERVICES by JACKSON.